Leaderboard

En | De
Sie sind hier: Respirationstrakt » Neoplasie 07. Dezember 2025
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Allergische Rhinitis - Pollinosis
Asthma
Bronchitis
COPD
Interstitielle Pneumopathien
Lungenembolie
Neoplasie
Pleuraerkrankungen
Pneumonie
SARS
Schlaf- Apnoe-Syndrom
Tuberkulose
Zystische Fibrose
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 7776  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 155514  
   
Clinical outcomes and predictive factors of immunotherapy efficacy in non-small-cell lung cancer brain metastases: a comparative study.
BMC Cancer
Wei Y, Li R, Liu X, Shi Y, Xu Y, Zhao J, Chen M, Wang M.
PMID: 41353112 [PubMed - as supplied by publisher]


Developing and Validating a Prediction Model for the Severe Pain-Fatigue-Sleep Disturbance Symptom Cluster in Patients with Lung Cancer Following Chemotherapy: A Machine Learning Analysis.
Semin Oncol Nurs
Teng L, Zhou Z, Yang Y, Dong Y, Sun J, Wang T.
PMID: 41353010 [PubMed - as supplied by publisher]


In situ reprogramming of tumor associated macrophages with versatile nano-epigenetic inhibitor for lung cancer therapy.
J Control Release
He M, Peng Q, Yang Q, Guan X, Liu Q, Chen R, Zhou D, Wang L, Zhang Y, Li S, Su J, Zhang L.
PMID: 41352646 [PubMed - as supplied by publisher]


Profiles of blood biomarkers in lung cancer.
Cancer Treat Res Commun
Zhu H, Li B, Lu J, Guo Z.
PMID: 41352206 [PubMed - as supplied by publisher]


Serum ZFPL1 as a clinical biomarker for diagnosis, progression tracking, and treatment response in lung cancer.
Cancer Treat Res Commun
Yu T, Liu H, Chen Y, Xu L, Pang X, Yang H, Chen S, Lu G, Feng J, Mo B.
PMID: 41352204 [PubMed - as supplied by publisher]


Microbiome Modulation in Lung Cancer Immunotherapy: Unveiling the Role of Respiratory and Gut Microbiota in the PD-1/PD-L1 Response.
Front Biosci (Landmark Ed)
Xu Y, Tao Y, Pan H, Wang Z, Wang H, Luo Q.
PMID: 41351413 [PubMed - indexed for MEDLINE]


A more selective risk-stratified, machine learning based, lung cancer thromboprophylaxis protocol following vats segmentectomy: a prospective cohort study.
Int J Surg
Wang J, Wang D, Cui S, Yang S, Zhao Q, Chen Q, Miao JB, Fu YL, Li H, Hu B.
PMID: 41351270 [PubMed - as supplied by publisher]


Primary Hepatic Neuroendocrine Tumour Misdiagnosed as Liver Metastases of Lung Adenocarcinoma: A Rare Case.
J Coll Physicians Surg Pak
Liu J, Ye L, Liu Q.
PMID: 41351108 [PubMed - indexed for MEDLINE]


Development and Validation of a Nomogram for Predicting Progression-Free Survival in Advanced Non-Small Cell Lung Cancer Patients Treated with Anlotinib.
J Coll Physicians Surg Pak
Wu Z, Zhou P, Zhao Y, Wang J, Gao S.
PMID: 41351099 [PubMed - indexed for MEDLINE]


The risk of symptomatic radiation pneumonitis in small cell lung cancer patients following sequential immunochemotherapy and radiotherapy: a multicenter retrospective cohort study.
Radiat Oncol
Liu Y, Zhang J, Zhang M, Wu W, Zhang H, Yin H.
PMID: 41350861 [PubMed - as supplied by publisher]


Retrospective analysis of the clinical features and prognosis of idiopathic pulmonary fibrosis combined with lung cancer.
BMC Cancer
Fu S, Li L, Ou Z, Lin C.
PMID: 41350847 [PubMed - indexed for MEDLINE]


Pathogenic mechanisms and resistance profiles of microbial pulmonary infections in lung cancer: a systematic review.
BMC Infect Dis
Sheervalilou M, Ghanei M, Arabfard M.
PMID: 41350628 [PubMed - as supplied by publisher]


Efficacy and safety of natural killer cell therapy for the treatment of advanced non-small cell lung cancer: A meta-analysis and systematic review.
Immunol Res
Li Z, Wang X, Chen S, Zhang P, Wang X, Ni X, Mou C.
PMID: 41350490 [PubMed - indexed for MEDLINE]


Exploring healthcare providers' perceptions of virtual reality in lung cancer treatment preparedness: a mixed-methods feasibility study for the development of EveryBreathMatters.
Sci Rep
Elkefi S, Wu R, Feiner SK, Chen L, Hembroff G, Matthews AK.
PMID: 41350374 [PubMed - as supplied by publisher]


Non-small cell lung cancer subtype classification based on cross-scale multi-instance learning.
Sci Rep
Jiang P, Chen W, Zheng G, Li X, Song X.
PMID: 41350354 [PubMed - indexed for MEDLINE]


Multicolor SERS-encoded immuno-cocktail for longitudinal precise tracking of CTCs phenotypes in lung cancer therapeutics.
Biosens Bioelectron
Fan M, Yu Z, Luo K, Chen P, Lin D, Lin Y, Lin X, Chen J, Feng S.
PMID: 41349442 [PubMed - as supplied by publisher]


Real-world evaluation of interstitial lung disease/pneumonitis in patients treated with trastuzumab deruxtecan for HER2-positive advanced or recurrent gastric cancer: a postmarketing surveillance study in Japan.
ESMO Open
Kawakami H, Uchino K, Hashimoto W, Muro K.
PMID: 41349223 [PubMed - as supplied by publisher]


Neoadjuvant Chemo-Immunotherapy for Surgically Resectable Non-Small Cell Lung Cancer: Balancing Promise and Pitfalls.
Clin Lung Cancer
Desai PA, Borghaei H, Edelman MJ.
PMID: 41349181 [PubMed - as supplied by publisher]


Incidence and survival of Lung Cancer: A retrospective population-based cohort (Monastir, Tunisia: 2002-2022).
PLoS One
Dhouib W, Maatouk A, Bennasrallah C, Kacem M, Doghri S, Trigui A, Bouazizi M, Milad L, Ben Fredj M, Bouanène I, Abroug H, Rouatbi N, Zaied S, Mokni M, Belguith Sriha A, Zemni I.
PMID: 41348719 [PubMed - indexed for MEDLINE]


A protocol for using human genetic data to identify circulating protein level changes that are the causal consequence of cancer processes.
PLoS One
Hobson LM, Martin RM, Smith-Byrne K, Davey Smith G, Hemani G, Gilbody JH, Yarmolinsky J, Bailey SER, Goudswaard LJ, Haycock PC.
PMID: 41348656 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 155514    Seite 1 von 7776  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

  Zeitfenster  
   

Sky right 1